nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—KCNMA1—pulmonary artery—chronic obstructive pulmonary disease	0.0788	0.27	CbGeAlD
Hydroflumethiazide—Gastric irritation—Aminophylline—chronic obstructive pulmonary disease	0.0334	0.0553	CcSEcCtD
Hydroflumethiazide—Epigastric discomfort—Aminophylline—chronic obstructive pulmonary disease	0.0247	0.0408	CcSEcCtD
Hydroflumethiazide—Angiitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.0213	0.0352	CcSEcCtD
Hydroflumethiazide—SLC12A3—respiratory system—chronic obstructive pulmonary disease	0.0192	0.0657	CbGeAlD
Hydroflumethiazide—Vasculitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.0185	0.0306	CcSEcCtD
Hydroflumethiazide—CA7—trachea—chronic obstructive pulmonary disease	0.0145	0.0496	CbGeAlD
Hydroflumethiazide—ATP1A1—Ion transport by P-type ATPases—ATP2C2—chronic obstructive pulmonary disease	0.014	0.135	CbGpPWpGaD
Hydroflumethiazide—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.014	0.0231	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.0132	0.0218	CcSEcCtD
Hydroflumethiazide—CA12—respiratory system—chronic obstructive pulmonary disease	0.0127	0.0436	CbGeAlD
Hydroflumethiazide—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.0122	0.0201	CcSEcCtD
Hydroflumethiazide—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.0122	0.0201	CcSEcCtD
Hydroflumethiazide—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.0115	0.019	CcSEcCtD
Hydroflumethiazide—CA12—connective tissue—chronic obstructive pulmonary disease	0.0112	0.0384	CbGeAlD
Hydroflumethiazide—KCNMA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0107	0.0366	CbGeAlD
Hydroflumethiazide—SLC12A3—lung—chronic obstructive pulmonary disease	0.0102	0.0349	CbGeAlD
Hydroflumethiazide—CA1—respiratory system—chronic obstructive pulmonary disease	0.0101	0.0345	CbGeAlD
Hydroflumethiazide—Gastric irritation—Prednisone—chronic obstructive pulmonary disease	0.01	0.0166	CcSEcCtD
Hydroflumethiazide—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.0099	0.0164	CcSEcCtD
Hydroflumethiazide—CA12—trachea—chronic obstructive pulmonary disease	0.00939	0.0322	CbGeAlD
Hydroflumethiazide—ATP1A1—respiratory system—chronic obstructive pulmonary disease	0.00851	0.0292	CbGeAlD
Hydroflumethiazide—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00817	0.0135	CcSEcCtD
Hydroflumethiazide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00787	0.027	CbGeAlD
Hydroflumethiazide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00763	0.0126	CcSEcCtD
Hydroflumethiazide—ATP1A1—connective tissue—chronic obstructive pulmonary disease	0.00749	0.0257	CbGeAlD
Hydroflumethiazide—Epigastric discomfort—Prednisone—chronic obstructive pulmonary disease	0.00738	0.0122	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00734	0.0121	CcSEcCtD
Hydroflumethiazide—KCNMA1—lung—chronic obstructive pulmonary disease	0.00704	0.0241	CbGeAlD
Hydroflumethiazide—ATP1A1—bronchus—chronic obstructive pulmonary disease	0.00701	0.024	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00692	0.0114	CcSEcCtD
Hydroflumethiazide—ATP1A1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00685	0.0235	CbGeAlD
Hydroflumethiazide—CA12—lung—chronic obstructive pulmonary disease	0.00675	0.0231	CbGeAlD
Hydroflumethiazide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00652	0.0224	CbGeAlD
Hydroflumethiazide—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00645	0.0107	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00645	0.0107	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00632	0.0104	CcSEcCtD
Hydroflumethiazide—ATP1A1—trachea—chronic obstructive pulmonary disease	0.00629	0.0216	CbGeAlD
Hydroflumethiazide—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00609	0.0101	CcSEcCtD
Hydroflumethiazide—CA5B—lung—chronic obstructive pulmonary disease	0.00605	0.0208	CbGeAlD
Hydroflumethiazide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00603	0.00997	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00594	0.00983	CcSEcCtD
Hydroflumethiazide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00593	0.00981	CcSEcCtD
Hydroflumethiazide—CA4—trachea—chronic obstructive pulmonary disease	0.00581	0.0199	CbGeAlD
Hydroflumethiazide—CA2—connective tissue—chronic obstructive pulmonary disease	0.00574	0.0197	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00558	0.00924	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00558	0.00924	CcSEcCtD
Hydroflumethiazide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00551	0.00911	CcSEcCtD
Hydroflumethiazide—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00547	0.00905	CcSEcCtD
Hydroflumethiazide—CA2—bronchus—chronic obstructive pulmonary disease	0.00537	0.0184	CbGeAlD
Hydroflumethiazide—CA1—lung—chronic obstructive pulmonary disease	0.00534	0.0183	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00527	0.00872	CcSEcCtD
Hydroflumethiazide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00527	0.00872	CcSEcCtD
Hydroflumethiazide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00525	0.018	CbGeAlD
Hydroflumethiazide—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00521	0.00861	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00511	0.00845	CcSEcCtD
Hydroflumethiazide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00508	0.0084	CcSEcCtD
Hydroflumethiazide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00498	0.00823	CcSEcCtD
Hydroflumethiazide—CA1—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00494	0.0474	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00486	0.0467	CbGpPWpGaD
Hydroflumethiazide—CA2—trachea—chronic obstructive pulmonary disease	0.00482	0.0165	CbGeAlD
Hydroflumethiazide—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00479	0.00793	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00474	0.00785	CcSEcCtD
Hydroflumethiazide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00459	0.00759	CcSEcCtD
Hydroflumethiazide—ATP1A1—lung—chronic obstructive pulmonary disease	0.00452	0.0155	CbGeAlD
Hydroflumethiazide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00441	0.00729	CcSEcCtD
Hydroflumethiazide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00441	0.00729	CcSEcCtD
Hydroflumethiazide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00437	0.00723	CcSEcCtD
Hydroflumethiazide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00437	0.00723	CcSEcCtD
Hydroflumethiazide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00434	0.00719	CcSEcCtD
Hydroflumethiazide—ATP1A1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00433	0.0416	CbGpPWpGaD
Hydroflumethiazide—CA4—lung—chronic obstructive pulmonary disease	0.00418	0.0143	CbGeAlD
Hydroflumethiazide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00415	0.00686	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00415	0.00686	CcSEcCtD
Hydroflumethiazide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00412	0.00681	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00406	0.00672	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00402	0.00665	CcSEcCtD
Hydroflumethiazide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00398	0.00658	CcSEcCtD
Hydroflumethiazide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00396	0.00656	CcSEcCtD
Hydroflumethiazide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00396	0.00656	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.00648	CcSEcCtD
Hydroflumethiazide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00388	0.00642	CcSEcCtD
Hydroflumethiazide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00374	0.00619	CcSEcCtD
Hydroflumethiazide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00373	0.00617	CcSEcCtD
Hydroflumethiazide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00367	0.00608	CcSEcCtD
Hydroflumethiazide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00366	0.00605	CcSEcCtD
Hydroflumethiazide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00346	0.00573	CcSEcCtD
Hydroflumethiazide—CA2—lung—chronic obstructive pulmonary disease	0.00346	0.0119	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00341	0.00564	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00338	0.00558	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00329	0.00544	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00321	0.00532	CcSEcCtD
Hydroflumethiazide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00317	0.00524	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00316	0.00523	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00315	0.00521	CcSEcCtD
Hydroflumethiazide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00306	0.00506	CcSEcCtD
Hydroflumethiazide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00301	0.00498	CcSEcCtD
Hydroflumethiazide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00301	0.00498	CcSEcCtD
Hydroflumethiazide—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00297	0.0286	CbGpPWpGaD
Hydroflumethiazide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00294	0.00486	CcSEcCtD
Hydroflumethiazide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00292	0.00484	CcSEcCtD
Hydroflumethiazide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00482	CcSEcCtD
Hydroflumethiazide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00291	0.00482	CcSEcCtD
Hydroflumethiazide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0029	0.00479	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00289	0.00478	CcSEcCtD
Hydroflumethiazide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00288	0.00477	CcSEcCtD
Hydroflumethiazide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.0047	CcSEcCtD
Hydroflumethiazide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.0028	0.00463	CcSEcCtD
Hydroflumethiazide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.0028	0.00463	CcSEcCtD
Hydroflumethiazide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—chronic obstructive pulmonary disease	0.00277	0.0267	CbGpPWpGaD
Hydroflumethiazide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00277	0.00459	CcSEcCtD
Hydroflumethiazide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00275	0.00455	CcSEcCtD
Hydroflumethiazide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00275	0.00454	CcSEcCtD
Hydroflumethiazide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00275	0.00454	CcSEcCtD
Hydroflumethiazide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00453	CcSEcCtD
Hydroflumethiazide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.00452	CcSEcCtD
Hydroflumethiazide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00437	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00259	0.00429	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00259	0.00429	CcSEcCtD
Hydroflumethiazide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00259	0.00429	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00254	0.0042	CcSEcCtD
Hydroflumethiazide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00253	0.00418	CcSEcCtD
Hydroflumethiazide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00253	0.00418	CcSEcCtD
Hydroflumethiazide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00247	0.00409	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00245	0.00405	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00241	0.00398	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00241	0.00398	CcSEcCtD
Hydroflumethiazide—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00239	0.023	CbGpPWpGaD
Hydroflumethiazide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00239	0.00395	CcSEcCtD
Hydroflumethiazide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00394	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00236	0.0039	CcSEcCtD
Hydroflumethiazide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00233	0.00385	CcSEcCtD
Hydroflumethiazide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00233	0.00385	CcSEcCtD
Hydroflumethiazide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00228	0.00377	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00376	CcSEcCtD
Hydroflumethiazide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00224	0.0037	CcSEcCtD
Hydroflumethiazide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00224	0.0037	CcSEcCtD
Hydroflumethiazide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00367	CcSEcCtD
Hydroflumethiazide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00367	CcSEcCtD
Hydroflumethiazide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00367	CcSEcCtD
Hydroflumethiazide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00367	CcSEcCtD
Hydroflumethiazide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00365	CcSEcCtD
Hydroflumethiazide—Headache—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00365	CcSEcCtD
Hydroflumethiazide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.00364	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.0022	0.00363	CcSEcCtD
Hydroflumethiazide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00219	0.00363	CcSEcCtD
Hydroflumethiazide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00217	0.0036	CcSEcCtD
Hydroflumethiazide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00359	CcSEcCtD
Hydroflumethiazide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00357	CcSEcCtD
Hydroflumethiazide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.0035	CcSEcCtD
Hydroflumethiazide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.0021	0.00347	CcSEcCtD
Hydroflumethiazide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.00347	CcSEcCtD
Hydroflumethiazide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00346	CcSEcCtD
Hydroflumethiazide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00209	0.00346	CcSEcCtD
Hydroflumethiazide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00209	0.00346	CcSEcCtD
Hydroflumethiazide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.00344	CcSEcCtD
Hydroflumethiazide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00205	0.00339	CcSEcCtD
Hydroflumethiazide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.00327	CcSEcCtD
Hydroflumethiazide—CA1—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.0019	0.0183	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00186	0.0179	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00169	0.0162	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00169	0.0162	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00166	0.0159	CbGpPWpGaD
Hydroflumethiazide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00156	0.00258	CcSEcCtD
Hydroflumethiazide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00152	0.00252	CcSEcCtD
Hydroflumethiazide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00151	0.0025	CcSEcCtD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00151	0.0145	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00151	0.0145	CbGpPWpGaD
Hydroflumethiazide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.00232	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00136	0.0131	CbGpPWpGaD
Hydroflumethiazide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00218	CcSEcCtD
Hydroflumethiazide—KCNMA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.0013	0.0125	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.00128	0.0123	CbGpPWpGaD
Hydroflumethiazide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00209	CcSEcCtD
Hydroflumethiazide—CA9—Cellular response to hypoxia—VEGFA—chronic obstructive pulmonary disease	0.00123	0.0118	CbGpPWpGaD
Hydroflumethiazide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00199	CcSEcCtD
Hydroflumethiazide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00199	CcSEcCtD
Hydroflumethiazide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00199	CcSEcCtD
Hydroflumethiazide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00198	CcSEcCtD
Hydroflumethiazide—CA1—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.00119	0.0114	CbGpPWpGaD
Hydroflumethiazide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00196	CcSEcCtD
Hydroflumethiazide—KCNMA1—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.00116	0.0111	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00114	0.011	CbGpPWpGaD
Hydroflumethiazide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00187	CcSEcCtD
Hydroflumethiazide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00182	CcSEcCtD
Hydroflumethiazide—KCNMA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00106	0.0102	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.00104	0.01	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00102	0.00982	CbGpPWpGaD
Hydroflumethiazide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00169	CcSEcCtD
Hydroflumethiazide—KCNMA1—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000999	0.0096	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	0.000997	0.00958	CbGpPWpGaD
Hydroflumethiazide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000994	0.00164	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000973	0.00935	CbGpPWpGaD
Hydroflumethiazide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000948	0.00157	CcSEcCtD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000938	0.00901	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000934	0.00898	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000931	0.00894	CbGpPWpGaD
Hydroflumethiazide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000916	0.00152	CcSEcCtD
Hydroflumethiazide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000881	0.00146	CcSEcCtD
Hydroflumethiazide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000873	0.00144	CcSEcCtD
Hydroflumethiazide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000872	0.00144	CcSEcCtD
Hydroflumethiazide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000868	0.00144	CcSEcCtD
Hydroflumethiazide—CA14—Metabolism—APIP—chronic obstructive pulmonary disease	0.000828	0.00796	CbGpPWpGaD
Hydroflumethiazide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000823	0.00136	CcSEcCtD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000819	0.00787	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000754	0.00724	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—APIP—chronic obstructive pulmonary disease	0.000754	0.00724	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—APIP—chronic obstructive pulmonary disease	0.000698	0.00671	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000583	0.0056	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000574	0.00552	CbGpPWpGaD
Hydroflumethiazide—CA9—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000564	0.00542	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000557	0.00535	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000549	0.00527	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000543	0.00522	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000534	0.00513	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GC—chronic obstructive pulmonary disease	0.000534	0.00513	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000512	0.00492	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000499	0.0048	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000499	0.0048	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000498	0.00478	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000496	0.00477	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	0.000486	0.00467	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	0.000486	0.00467	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000462	0.00444	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000457	0.00439	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000456	0.00438	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000451	0.00434	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000451	0.00434	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	0.00045	0.00432	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	0.00045	0.00432	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000446	0.00429	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000431	0.00415	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000418	0.00402	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000403	0.00387	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000392	0.00376	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000369	0.00354	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000365	0.00351	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	0.000359	0.00345	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000354	0.0034	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	0.000344	0.00331	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000339	0.00326	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000333	0.00321	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000332	0.00319	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000332	0.00319	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GC—chronic obstructive pulmonary disease	0.00033	0.00317	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00032	0.00307	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000307	0.00295	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000298	0.00286	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000292	0.0028	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	0.00029	0.00279	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000288	0.00277	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000288	0.00276	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000282	0.00271	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000269	0.00259	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000265	0.00255	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000265	0.00255	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000263	0.00253	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000262	0.00252	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000262	0.00252	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000259	0.00249	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000246	0.00236	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000243	0.00233	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000242	0.00233	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000239	0.0023	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000239	0.0023	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000238	0.00228	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000229	0.0022	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000222	0.00213	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00212	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00212	CbGpPWpGaD
Hydroflumethiazide—SLC12A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000219	0.00211	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000218	0.0021	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000218	0.0021	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000217	0.00209	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000209	0.002	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.00196	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000202	0.00194	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000199	0.00192	CbGpPWpGaD
Hydroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000199	0.00191	CbGpPWpGaD
Hydroflumethiazide—ATP1A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000199	0.00191	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000196	0.00188	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000194	0.00186	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000188	0.00181	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	0.000186	0.00179	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000186	0.00178	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000186	0.00178	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000184	0.00177	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000184	0.00177	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000181	0.00174	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000181	0.00174	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00018	0.00173	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000178	0.00171	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000177	0.0017	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.00169	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00017	0.00164	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000169	0.00163	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000169	0.00162	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000169	0.00162	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000168	0.00161	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000163	0.00157	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000162	0.00156	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00154	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00154	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000158	0.00152	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000157	0.0015	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000157	0.0015	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.0015	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.00015	0.00144	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.00144	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00143	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000143	0.00137	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	0.00014	0.00135	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000138	0.00133	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000136	0.00131	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000134	0.00129	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.00126	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00013	0.00125	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	0.000129	0.00124	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000128	0.00123	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000125	0.0012	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000125	0.0012	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000123	0.00118	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00012	0.00115	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	0.00012	0.00115	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00114	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000115	0.0011	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000114	0.0011	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000114	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00109	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00011	0.00105	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	0.000109	0.00105	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	0.000109	0.00105	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00105	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000108	0.00104	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000104	0.001	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000104	0.001	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000101	0.000969	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	0.000101	0.000969	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	9.65e-05	0.000927	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.56e-05	0.000919	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	8.04e-05	0.000773	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	7.71e-05	0.000741	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.69e-05	0.000739	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	7.39e-05	0.000711	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.38e-05	0.000709	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.07e-05	0.00068	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	6.5e-05	0.000625	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	6.22e-05	0.000598	CbGpPWpGaD
